VALLON PHARMACEUTICALS INC (VLON) Stock Balance Sheet
USA - NASDAQ:VLON - US92023M1018 - Common Stock
0.4 USD
-0.06 (-13.04%)
0.3901 USD
-0.01 (-2.48%)
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 3.78M | 3.70M | 110.00K | 3.82M | 610.00K | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 0 | 3.81M | null | null | null | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 371.00K | 619.00K | 570.00K | 100.00K | 20.00K | |||
| Total Current Assets | 4.15M | 8.13M | 670.00K | 3.92M | 640.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | null | 206.00K | 280.00K | 350.00K | 0 | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 0 | null | null | null | null | |||
| Total Non-Current Assets | 0 | 206.00K | 290.00K | 360.00K | 0 | |||
| TOTAL ASSETS | 4.15M | 8.34M | 960.00K | 4.28M | 640.00K | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 0 | 97.00K | 150.00K | 90.00K | 0 | |||
| Accrued Expenses | 401.00K | 353.00K | 640.00K | 220.00K | 50.00K | |||
| Accounts Payable | 977.00K | 918.00K | 1.23M | 250.00K | 290.00K | |||
| Other Current Liabilities | 432.00K | 1.08M | 210.00K | 260.00K | 150.00K | |||
| Total Current Liabilities | 1.81M | 2.44M | 2.23M | 810.00K | 490.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 72.00K | 180.00K | 250.00K | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | null | null | null | null | null | |||
| Total Non-Current Liabilities | 0 | 72.00K | 180.00K | 250.00K | 0 | |||
| TOTAL LIABILITIES | 1.81M | 2.52M | 2.41M | 1.06M | 490.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -28.93M | -21.90M | -12.60M | -7.78M | -4.31M | |||
| Additional Paid In Capital | 31.27M | 27.72M | 11.15M | 10.97M | 4.45M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 1.00K | 680 | null | 20.00K | 10.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 0 | -2.68K | null | null | null | |||
| Shares Outstanding | 13.48M | 6.81M | 6.81M | 6.76M | 6.76M | |||
| Tangible Book Value per Share | 0.17371 | 0.85398 | -0.2129 | 0.4749 | 0.0222 | |||
| Total Shareholders' Equity | 2.34M | 5.82M | -1.45M | 3.21M | 150.00K | |||
| TOTAL LIABILITIES AND EQUITY | 4.15M | 8.34M | 960.00K | 4.28M | 640.00K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.01 | -0.12 | 0.08 | N/A | |||
| Current Ratio | 2.29 | 3.32 | 0.30 | 4.84 | 1.31 | |||
| Return On Assets (ROA) | -169.17% | -111.61% | -502.08% | -80.84% | -673.44% | |||
| Return On Equity (ROE) | -299.91% | -159.90% | N/A | -107.79% | -2873.33% | |||
All data in USD , ROIC based on taxRate of 0.21